Hca Healthcare, Inc. (HCA) Stock Price & Analysis
Hca Healthcare, Inc. (HCA) rose 1.51% to USD 382.19 as of July 25, 2026 at 01:13 UTC, according to Nexqual real-time market data.
HCA last closed at USD 376.5; the session ranged USD 376.48–399 on volume of 2,700,418 shares. Market capitalization is $84.78B, with a 52-week range of USD 330–556.52 (NYQ). Source: Nexqual, July 25, 2026 at 01:13 UTC.
Key Statistics (as of July 25, 2026 at 01:13 UTC)
| Price | USD 382.19 |
|---|---|
| Change | ▲ 1.51% (up) |
| Previous Close | USD 376.5 |
| Open | USD 381.53 |
| Day Range | USD 376.48 – 399 |
| 52-Week Range | USD 330 – 556.52 |
| Volume | 2,700,418 shares |
| Market Cap | $84.78B |
| Exchange | NYQ |
Technical Analysis (HCA)
Nexqual's technical model rates HCA "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:13 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 49.71 (neutral) |
| vs SMA50 | Below (USD 388.99) |
| MACD | -5.42 (negative) |
Analyst Ratings (HCA)
Wall Street analysts rate HCA "Buy" based on 20 analysts, with a mean price target of USD 469.1 (range USD 369–635), per Nexqual as of July 25, 2026 at 01:13 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 20 |
| Mean Target | USD 469.1 |
| High Target | USD 635 |
| Low Target | USD 369 |
| Buy / Hold / Sell | 14 / 10 / 1 |
Earnings (HCA)
| Next Earnings Date | 2026-07-24 |
|---|---|
| EPS Estimate | USD 7 |
| Revenue Estimate | $19.56B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 7.59 vs est 7.5 ▲ beat |
| 2026-03-31 | USD 7.15 vs est 7.13 ▲ beat |
| 2025-12-31 | USD 8.01 vs est 7.48 ▲ beat |
| 2025-09-30 | USD 6.96 vs est 5.73 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
Financials & Fundamentals (HCA)
| Total Revenue | $76.39B |
|---|---|
| Revenue Growth (YoY) | +4.30% |
| Gross Margin | +41.61% |
| Operating Margin | +14.98% |
| Profit Margin | +8.89% |
| Current Ratio | 0.83 |
| Total Cash | $1.06B |
| Total Debt | $49.84B |
| Free Cash Flow | $5.73B |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
Financial Health Score (HCA)
Nexqual rates Hca Healthcare, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:13 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 42%, operating 15% |
| Balance Sheet | Mixed — $1.06B cash vs $49.8B debt |
| Cash Flow | Solid — FCF $5.73B, 8% margin |
| Efficiency | Mixed — No data |
Ownership (HCA)
| Insider Ownership | +16.21% |
|---|---|
| Institutional Ownership | +78.55% |
| Shares Outstanding | 221.84M |
| Float | 149.49M |
| Short % of Float | +3.66% |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
Leadership (HCA)
Hca Healthcare, Inc. is led by Samuel N. Hazen (age 65), CEO & Director, per Nexqual as of July 25, 2026 at 01:13 UTC.
| CEO & Director | Samuel N. Hazen (age 65) |
|---|---|
| CFO & Executive VP | Michael A. Marks (age 55) |
| Executive VP & COO | Jon Mack Foster (age 63) |
| Founder & Chairman Emeritus | Thomas F. Frist Jr. (age 86) |
| Vice President of Investor Relations | Frank George Morgan C.F.A. |
Major Backers & Investors (HCA)
Notable institutional backers of Hca Healthcare, Inc. include Sanders Capital, LLC, First Eagle Investment Management, LLC, FMR, LLC, according to Nexqual as of July 25, 2026 at 01:13 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sanders Capital, LLC | 4.04% |
| First Eagle Investment Management, LLC | 2.46% |
| FMR, LLC | 1.98% |
| GROWTH FUND OF AMERICA | 1.81% |
| Wellington Management | 1.76% |
| Capital International Investors | 1.37% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.01% |
| BlackRock | 6.95% |
| State Street | 4.25% |
| Geode Capital | 1.66% |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
From Hca Healthcare, Inc.'s Latest SEC 10-K Filing (filed 2026-02-10)
Key Strengths & Strategy (as disclosed to the SEC)
- CMS is implementing a new payment and service delivery model, the Wasteful and Inappropriate Service Reduction ("WISeR") model, in six states in 2026, including Texas.
Partnerships
- Most of our ASCs are operated through partnerships or limited liability companies, with majority ownership of each partnership or limited liability company typically held by a general partner or member that is an affiliate of HCA.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UHS | Universal Health Services, Inc. | USD 155.75 | ▲ 4.29% |
| THC | Tenet Healthcare Corporation | USD 233.2 | ▲ 19.38% |
| HUM | Humana Inc. | USD 389.32 | ▼ 2.08% |
| CI | The Cigna Group | USD 289.57 | ▲ 1.66% |
| CNC | Centene Corporation | USD 63.41 | ▼ 3.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:13 UTC. This page is informational and not investment advice.